What's eating you? Strongyloides stercoralis

Cutis

Volumn 71, Issue 1, 2003, Pages 22-24

  Elston, Dirk M ^a   Czarnik, Katherine ^b   Brockett, Royce ^b   Keeling, James H ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; IVERMECTIN; PREDNISOLONE; TIABENDAZOLE;

ARTICLE; BLOOD CELL COUNT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FECES ANALYSIS; FOOD INTAKE; HUMAN; LABORATORY TEST; LARVA; MORBIDITY; NEURODERMATITIS; NONHUMAN; OOCYTE; PRURIGO; PRURITUS; PURPURA; RASH; SIDE EFFECT; SKIN BIOPSY; SKIN DEFECT; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TREATMENT OUTCOME; URTICARIA; ANIMAL; ISOLATION AND PURIFICATION; PATHOGENICITY; PATHOLOGY; REVIEW; SKIN DISEASE;

ANIMALS; HUMANS; SKIN DISEASES; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 0037259031     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mahmoud AA. Strongyloidiasis. Clin Infect Dis. 1996;23:949-953.
2. Nutman TB, Ottesen EA, Ieng S, et al. Eosinophilia in Southeast Asian refugees: evaluation at a referral center. J Infect Dis. 1987;155:309-313.
3. Chaudhary K, Smith RJ, Himelright IM, et al. Case report: purpura in disseminated strongyloidiasis. Am J Med Sci. 1994;308:186-191.
4. Gordon SM, Gal AA, Solomon AR, et al. Disseminated strongyloidiasis with cutaneous manifestations in an immunocompromised host. J Am Acad Dermatol. 1994;31:255-259.
5. Jacob CI, Patten SF. Strongyloides stercoralis infection presenting as generalized prurigo nodularis and lichen simplex chronicus. J Am Acad Dermatol. 1999;41:357-361.
6. Dreyer G, Fernandes-Silva E, Alves S, et al. Patterns of detection of Strongyloides stercoralis in stool specimens: implications for diagnosis and clinical trials. J Clin Microbiol. 1996;34:2569-2571.
7. Jongwutiwes S, Charoenkorn M, Sitthichareonchai P, et al. Increased sensitivity of routine laboratory detection of Strongyloides stercoralis and hookworm by agar-plate culture. Trans R Soc Trop Med Hyg. 1999;93:398-400.
8. Thomas MC, Costello SA. Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int J Clin Pract. 1998;52:520-521.
9. Chieffi PP, Chiattone CS, Feltrim EN, et al. Coinfection by Strongyloides stercoralis in blood donors infected with human T-cell leukemia/lymphoma virus type 1 in Sao Paulo City, Brazil. Menorias do Instituto Oswaldo Cruz. 2000;95:711-712.
10. Sorensen M, Andersen O, Friis-Moller A, et al. Fatal outcome of Strongyloides stercoralis infection in a patient with no previously known immunosuppression. Ugeskrift Laeger. 2000;162:2894-2895.
11. Setoyama M, Fukumaru S, Takasaki T, et al. SLE with death from acute massive pulmonary hemorrhage caused by disseminated strongyloidiasis. Scand J Rhematol. 1997;26:389-391.
12. de Paula FM, de Castro E, Goncalves-Pires M, et al. Parasitological and immunological diagnoses of Strongyloides in immunocompromised and non-immunocompromised children in Uberlandia, State of Minas Gerais, Brazil. Rvisita do Instituto de Medicina Tropical de Sao Paulo. 2000;42:51-55.
13. Abdul-Fattah MM, Nasr ME, Yousef SM, et al. Efficacy of ELISA in diagnosis of strongyloidiasis among the immune-compromised patients. J Egypt Soc Parasitol. 1995;25:491-498.
14. Marti H, Haji HJ, Savioli L, et al. A comparative trial of a single-dose of ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg. 1996;55:477-481.
15. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg. 1994;88:344-345.
16. Satoh M, Toma H, Sato Y, et al. Production of a high level of specific IgG4 antibody associated with resistance to albendazole treatment in HLA-DRB1*0901-positive patients with strongyloidiasis. Am J Trop Med Hyg. 1999;61:668-671.
17. Gann PH, Neva FA, Gam AA. A randomized trial of single-and two-dose ivermectin versus thibendazole for the treatment of strongyloidiasis. J Infect Dis. 1994;169:1076-1079.